Silver Lake Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.8M | Sell |
47,073
-199
| -0.4% | -$42.8K | 4.23% | 2 |
|
|
2026
Q1 | $10.3M | Sell |
47,272
-214
| -0.5% | -$47.5K | 4.08% | 3 |
|
|
2025
Q4 | $10.9M | Buy |
47,486
+157
| +0.3% | +$35.8K | 4.21% | 2 |
|
|
2025
Q3 | $11M | Buy |
47,329
+253
| +0.5% | +$51.5K | 4.36% | 2 |
|
|
2025
Q2 | $8.74M | Buy |
47,076
+117
| +0.2% | +$21.7K | 3.72% | 3 |
|
|
2025
Q1 | $9.84M | Buy |
46,959
+254
| +0.5% | +$49.4K | 4.29% | 2 |
|
|
2024
Q4 | $8.3M | Sell |
46,705
-1,631
| -3% | -$300K | 3.65% | 2 |
|
|
2024
Q3 | $9.55M | Sell |
48,336
-9,091
| -16% | -$1.7M | 3.91% | 1 |
|
|
2024
Q2 | $9.85M | Buy |
57,427
+1,456
| +3% | +$241K | 4.44% | 1 |
|
|
2024
Q1 | $10.2M | Buy |
55,971
+847
| +2% | +$146K | 4.54% | 1 |
|
|
2023
Q4 | $8.54M | Buy |
55,124
+1,428
| +3% | +$208K | 4.79% | 1 |
|
|
2023
Q3 | $8M | Buy |
53,696
+631
| +1% | +$92.6K | 4.94% | 1 |
|
|
2023
Q2 | $7.15M | Buy |
53,065
+265
| +0.5% | +$38.9K | 3.82% | 1 |
|
|
2023
Q1 | $8.41M | Buy |
52,800
+493
| +0.9% | +$75.4K | 4.67% | 1 |
|
|
2022
Q4 | $8.45M | Buy |
52,307
+412
| +0.8% | +$63.2K | 5.15% | 1 |
|
|
2022
Q3 | $6.96M | Buy |
51,895
+359
| +0.7% | +$51.5K | 4.08% | 1 |
|
|
2022
Q2 | $7.89M | Buy |
51,536
+244
| +0.5% | +$37.3K | 4.31% | 1 |
|
|
2022
Q1 | $8.31M | Sell |
51,292
-14,633
| -22% | -$2.13M | 3.95% | 1 |
|
|
2021
Q4 | $8.93M | Sell |
65,925
-1,562
| -2% | -$185K | 4.13% | 1 |
|
|
2021
Q3 | $7.28M | Buy |
67,487
+783
| +1% | +$89.5K | 3.59% | 1 |
|
|
2021
Q2 | $7.75M | Sell |
66,704
-570
| -0.8% | -$64.2K | 3.71% | 1 |
|
|
2021
Q1 | $7.28M | Buy |
67,274
+833
| +1% | +$89.1K | 3.71% | 1 |
|
|
2020
Q4 | $7.12M | Sell |
66,441
-345
| -0.5% | -$33.2K | 3.9% | 1 |
|
|
2020
Q3 | $5.85M | Sell |
66,786
-1,141
| -2% | -$107K | 3.6% | 1 |
|
|
2020
Q2 | $6.67M | Buy |
67,927
+647
| +1% | +$57K | 4.27% | 1 |
|
|
2020
Q1 | $5.13M | Buy |
67,280
+383
| +0.6% | +$32.6K | 3.77% | 5 |
|
|
2019
Q4 | $5.92M | Buy |
66,897
+1,419
| +2% | +$118K | 3.57% | 2 |
|
|
2019
Q3 | $4.96M | Buy |
65,478
+40,998
| +167% | +$2.81M | 3.2% | 6 |
|
|
2019
Q2 | $1.78M | Buy |
24,480
+273
| +1% | +$21.5K | 1.18% | 37 |
|
|
2019
Q1 | $1.95M | Sell |
24,207
-1,232
| -5% | -$101K | 1.32% | 34 |
|
|
2018
Q4 | $2.35M | Sell |
25,439
-583
| -2% | -$51.3K | 1.74% | 26 |
|
|
2018
Q3 | $2.46M | Sell |
26,022
-103
| -0.4% | -$9.77K | 1.5% | 29 |
|
|
2018
Q2 | $1.89M | Buy |
26,125
+321
| +1% | +$31.4K | 1.51% | 29 |
|
|
2018
Q1 | $2.44M | Buy |
25,804
+115
| +0.4% | +$12.6K | 1.81% | 23 |
|
|
2017
Q4 | $2.48M | Sell |
25,689
-149
| -0.6% | -$14K | 1.77% | 24 |
|
|
2017
Q3 | $2.3M | Sell |
25,838
-1,348
| -5% | -$103K | 1.75% | 25 |
|
|
2017
Q2 | $1.97M | Sell |
27,186
-37
| -0.1% | -$2.49K | 1.46% | 28 |
|
|
2017
Q1 | $1.77M | Sell |
27,223
-912
| -3% | -$57.3K | 1.34% | 32 |
|
|
2016
Q4 | $1.76M | Buy |
28,135
+438
| +2% | +$26.7K | 1.36% | 34 |
|
|
2016
Q3 | $1.75M | Buy |
27,697
+157
| +0.6% | +$10.2K | 1.3% | 34 |
|
|
2016
Q2 | $1.71M | Buy |
27,540
+139
| +0.5% | +$8.47K | 1.27% | 38 |
|
|
2016
Q1 | $1.56M | Buy |
27,401
+214
| +0.8% | +$11.9K | 1.33% | 35 |
|
|
2015
Q4 | $1.61M | Buy |
27,187
+168
| +0.6% | +$9.68K | 1.44% | 32 |
|
|
2015
Q3 | $1.47M | Buy |
27,019
+98
| +0.4% | +$6.38K | 1.32% | 35 |
|
|
2015
Q2 | $1.81M | Sell |
26,921
-33,844
| -56% | -$2.21M | 1.47% | 31 |
|
|
2015
Q1 | $3.56M | Sell |
60,765
-14,807
| -20% | -$895K | 2.86% | 6 |
|
|
2014
Q4 | $4.95M | Sell |
75,572
-371
| -0.5% | -$23.4K | 4.02% | 2 |
|
|
2014
Q3 | $4.39M | Buy |
75,943
+527
| +0.7% | +$29.3K | 3.59% | 2 |
|
|
2014
Q2 | $4.08M | Buy |
75,416
+348
| +0.5% | +$18.3K | 3.37% | 3 |
|
|
2014
Q1 | $3.86M | Buy |
75,068
+484
| +0.6% | +$24.5K | 3.45% | 3 |
|
|
2013
Q4 | $3.94M | Buy |
+74,584
| New | +$3.67M | 3.35% | 4 |
|
Other funds holding ABBV
Silver Lake Advisory's ABBV Position: Q2 2026 in Review
Silver Lake Advisory reduced its AbbVie (ABBV) stake by 0.42% in Q2 2026, selling an estimated $42.8K and leaving 47,073 shares worth $11.8M. The position accounts for 4.23% of the portfolio, ranked #2.
Silver Lake Advisory first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Silver Lake Advisory held 47,073 shares of AbbVie worth $11.8M as of Q2 2026.
- Silver Lake Advisory sold 199 AbbVie shares in Q2 2026, an estimated $42.8K.
- AbbVie made up 4.23% of Silver Lake Advisory's portfolio in Q2 2026, its #2 holding.
- Silver Lake Advisory first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Silver Lake Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.